Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy

Di Maio Velia Chiara; Barbaliscia Silvia; Teti Elisabetta; Lenci Ilaria; Aragri Marianna; Polilli Ennio; Gianserra Laura; Palitti Valeria Pace; Bruzzone Bianca; Paolucci Stefania; Coppola Nicola; Ruggiero Tina; Pollicino Teresa; Niero Fosca; Micheli Valeria; Di Biagio Antonio; Bertoli Ada; Sticchi Laura; Maida Ivana; Francioso Simona; Foroghi Luca; Calvaruso Vincenza; Morisco Filomena; Lleo Ana; Ciancio Alessia; Maserati Renato; Brancaccio Giuseppina; Puoti Massimo; Toniutto Pierluigi; Vullo Vincenzo; Aghemo Alessio; Cariti Giuseppe; Bonora Stefano; Babudieri Sergio; Gubertini Guido A.; Rendina Maria; Pellicelli Adriano M.; Sangiovanni Vincenzo; Ciaccio Antonio; Taliani Gloria; Raimondo Giovanni; Craxi Antonio; Pasquazzi Caterina; Sarmati Loredana; Parruti Giustino; Angelico Mario; Andreoni Massimo; Cento Valeria; Perno Carlo Federico; Ceccherini-Silberstein Francesca

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy

【24h】

Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy

机译：NS3，NS5A和NS5B抗性相关取代的NS3，NS5A和NSA-Footty HCV-3患者的特征和患病率

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases 》 |2017年第1期| 共2页
作者
Di Maio Velia Chiara; Barbaliscia Silvia; Teti Elisabetta; Lenci Ilaria; Aragri Marianna; Polilli Ennio; Gianserra Laura; Palitti Valeria Pace; Bruzzone Bianca; Paolucci Stefania; Coppola Nicola; Ruggiero Tina; Pollicino Teresa; Niero Fosca; Micheli Valeria; Di Biagio Antonio; Bertoli Ada; Sticchi Laura; Maida Ivana; Francioso Simona; Foroghi Luca; Calvaruso Vincenza; Morisco Filomena; Lleo Ana; Ciancio Alessia; Maserati Renato; Brancaccio Giuseppina; Puoti Massimo; Toniutto Pierluigi; Vullo Vincenzo; Aghemo Alessio; Cariti Giuseppe; Bonora Stefano; Babudieri Sergio; Gubertini Guido A.; Rendina Maria; Pellicelli Adriano M.; Sangiovanni Vincenzo; Ciaccio Antonio; Taliani Gloria; Raimondo Giovanni; Craxi Antonio; Pasquazzi Caterina; Sarmati Loredana; Parruti Giustino; Angelico Mario; Andreoni Massimo; Cento Valeria; Perno Carlo Federico; Ceccherini-Silberstein Francesca;
展开▼
作者单位

Univ Roma Tor Vergata Det Expt Med &

Surg Rome Italy;

Univ Roma Tor Vergata Det Expt Med &

Surg Rome Italy;

Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;

Univ Hosp Rome Tor Vergata Hepatol Unit Rome Italy;

Univ Roma Tor Vergata Det Expt Med &

Surg Rome Italy;

Pescara Gen Hosp Infect Dis Unit Pescara Italy;

Univ Roma La Sapienza Infect Dis St Andrea Hosp Rome Italy;

Pescara Gen Hosp Hepatol Unit Pescara Italy;

IRCCS AOU San Martino IST Hyg Unit Genoa Italy;

IRCCS Policlin Fdn San Matteo Mol Virol Pavia Italy;

Univ Naples 2 Infect Dis &

Viral Hepatitis Unit Naples Italy;

Amedeo Savoia Hosp Lab Microbiol &

Virol ASL Citta Torino Turin Italy;

Univ Hosp Messina Dept Internal Med Messina Italy;

ASST Fatebenefratelli Sacco Div Infect Dis Milan Italy;

ASST Fatebenefratelli Sacco Clin Microbiol Virol &

Bioemergencies Milan Italy;

IRCCS AOU San Martino IST Infect Dis Genoa Italy;

Univ Roma Tor Vergata Det Expt Med &

Surg Rome Italy;

IRCCS AOU San Martino IST Hyg Unit Genoa Italy;

Univ Sassari Infect Dis Unit Sassari Italy;

Univ Hosp Rome Tor Vergata Hepatol Unit Rome Italy;

Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;

P Giaccone Univ Hosp Gastroenterol Palermo Italy;

Univ Federico II Naples Dept Clin Med &

Surg Naples Italy;

Humanitas Univ Dept Biomed Sci Milan Italy;

Univ Turin City Hlth &

Sci Molinette Turin Hosp Dept Med Sci Unit Gastroenterol Turin Italy;

Univ Pavia Inst Infect Dis Pavia Italy;

Univ Naples 2 Infect Dis &

Viral Hepatitis Unit Naples Italy;

Hosp Niguarda Ca Granda Dept Infect Dis Milan Italy;

Dept Med Sci Expt &

Clin Med Liver Transplant Sect Udine Italy;

Sapienza Univ Rome Dept Publ Hlth &

Infect Dis Rome Italy;

IRCCS Fdn Ca Granda Osped Maggiore Policlin Unit Gastroenterol &

Hepatol Milan Italy;

Univ Turin Amedeo Savoia Hosp Dept Med Sci Unit Infect Dis Turin Italy;

Univ Turin Amedeo Savoia Hosp Dept Med Sci Unit Infect Dis Turin Italy;

Univ Sassari Infect Dis Unit Sassari Italy;

ASST Fatebenefratelli Sacco Div Infect Dis Milan Italy;

Univ Hosp Dept Emergency &

Organ Transplantat Gastroenterol Sect Bari Italy;

San Camillo Forlanini Hosp Hepatol Unit Rome Italy;

Hosp Cotugno Naples Italy;

Univ Milano Bicocca Dept Med &

Surg Milan Italy;

Univ Roma La Sapienza Dept Clin Med Infect &

Trop Dis Unit Rome Italy;

Univ Hosp Messina Dept Internal Med Messina Italy;

P Giaccone Univ Hosp Gastroenterol Palermo Italy;

Univ Roma La Sapienza Infect Dis St Andrea Hosp Rome Italy;

Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;

Pescara Gen Hosp Infect Dis Unit Pescara Italy;

Univ Hosp Rome Tor Vergata Hepatol Unit Rome Italy;

Univ Hosp Rome Tor Vergata Infect Dis Rome Italy;

Univ Roma Tor Vergata Det Expt Med &

Surg Rome Italy;

Univ Roma Tor Vergata Det Expt Med &

Surg Rome Italy;

Univ Roma Tor Vergata Det Expt Med &

Surg Rome Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. HCV NS5A and NS5B Enhance Expression of Human Ceramide Glucosyltransferase Gene [J] . Jia Guo, Ran Yan, Guo-dong Xu, 中国病毒学：英文版 . 2012 ,第001期
2. Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy [J] . Di Maio Velia Chiara, Barbaliscia Silvia, Teti Elisabetta, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017 ,第Suppla1期

机译：NS3，NS5A和NS5B抗性相关取代的NS3，NS5A和NSA-Footty HCV-3患者的特征和患病率
3. Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir [J] . Sarrazin Christoph, Dvory-Sobol Hadas, Svarovskaia Evguenia S., Gastroenterology . 2016 ,第3期

机译：丙型肝炎病毒NS5A，NS5B或NS3中与耐药性相关的取代发生率以及Ledipasvir和Sofosbuvir的治疗结果
4. Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance‐associated substitutions in na?ve na?ve patients from Argentina [J] . Martínez Alfredo P., García Gabriel, Ridruejo Ezequiel, Journal of Medical Virology . 2019 ,第11期

机译：丙型肝炎病毒基因型1感染：Na-Ve Na've患者NS5A和NS5B抗性相关取代的患病率来自阿根廷
5. Prevalence and Characteristics of Neuropathic Pain in 358 Patients with Leprosy [C] . Patrick R.N.A.G. Stump, Rosemari Baccarelli, Lucia H.S.C. Marciano, World Congress on Pain . 2003

机译：358例麻风病患者神经性疼痛的患病率和特征
6. The implications of molecular diagnostics in clinicopathologic correlations in two disease processes: PSA serum levels in acute illnesses, and, prevalence of activated protein C resistance and factor V mutation in patients with thrombosis and in control patients by ethnic group. [D] . Honda, Stacey Ann Akemi. 2002

机译：分子诊断在两种疾病过程中的临床病理相关性中的意义：急性疾病中PSA血清水平，以及血栓形成患者和对照患者（按种族）的活化蛋白C抗性和因子V突变的患病率。
7. Prevalence of Single and Multiple Natural NS3 NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy [O] . Ada Bertoli, Maria Chiara Sorbo, Marianna Aragri, -1

机译：在意大利1-4型丙型肝炎病毒基因中单个和多个天然NS3NS5A和NS5B抗药性相关替代基因的流行
8. Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection [O] . Pooneh Rahimi, Heidar Sharafi, Golnaz Bahramali, 2021

机译：伊朗慢性丙型肝炎感染患者天然存在的NS5A和NS5B抗性相关取代的患病率

Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy

著录项

相似文献

相关主题

期刊订阅